Novo Nordisk selects Gefion AI Supercomputer to advance drug discovery and healthcare innovation
PARIS, June 11, 2025 /PRNewswire/ -- NVIDIA GTC Paris at VivaTech -- DCAI today announced that Novo Nordisk has become a customer...
Month: June 2025
iotaMotion Announces Issuance of U.S. Patent for Robotic-Assisted Cochlear Implantation Technology
ST. PAUL, Minn., June 11, 2025 /PRNewswire/ -- iotaMotion, Inc., a leader in robotic-assisted systems for cochlear implant surgery, today announced...
Benchling Announces Collaboration with Merck on Vaccine Bioanalysis
Unified platform drives bioanalytical capacity, throughput, and efficiency in regulated environment SAN FRANCISCO, June 11, 2025 /PRNewswire/ -- Benchling announced...
Capital Rx Acquires Care Navigation Company Amino Health
With Amino Health, Capital Rx launches Judi Care, a next-generation care navigation solution that helps health plan members avoid the...
Lembas Emerges from Stealth with Breakthrough Discovery in Natural GLP-1 for Weight Management
Following successful validation, the AI-driven bioactive discovery company announces $3.6 mm round to scale next-gen food-as-medicine metabolic health solutions TEL...
Project 55 Launches Free Mental Health First Responder Training for Public Use
Evidence-informed course equips non-professionals to respond to mental health crises with practical, scalable skills Project 55 Logo LADERA RANCH, Calif.,...
Femasys Announces Partnership with Carolinas Fertility Institute, One of America’s Best Fertility Clinics, to Offer FemaSeed® in its More than 8 Locations
-- Femasys continues to expand access and market share for its first-line infertility treatment option, FemaSeed® -- ATLANTA, June 11,...
Fate Therapeutics Announces Updated Clinical Data for FT819 Off-the-shelf CAR T-cell Product Candidate Demonstrating Durability of Drug-free Remission for Severe Lupus Nephritis at EULAR 2025 Congress
All three patients treated with FT819 following fludarabine-free conditioning regimen for severe lupus nephritis achieve Primary Efficacy Renal Response (PERR);...
Silo Pharma Secures Biomarker Patent for Novel PTSD Therapeutic SPC-15 as Clinical Trial Nears
SARASOTA, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“Silo” or the “Company”), a developmental stage...
Precision Neuroscience Expands Leadership Team With Key Hires From Meta and FDA
Vanessa Tolosa joins as Senior Vice President of Research and Development; Vivek Pinto as Director of Medical AffairsNEW YORK, June...
Management Confidence: Shineco Executives Launch up to $2M Open-Market Stock Purchase Program
BEIJING, June 11, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic...
Windtree Receives Offer for Its Preclinical Oncology Drug Candidate
Company to receive $7.0 million up front for its preclinical oncology drug candidate Up to $130.0 million in milestone payments starting...
Lisata Therapeutics to Present at the 2025 BIO International Convention
BASKING RIDGE, N.J., June 11, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage...
Veru to Participate in the Virtual BTIG Obesity Health Forum
MIAMI, FL, June 11, 2025 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on...
GraceMed announces appointment of Dan Pawliw as Chief Executive Officer
Dan Pawliw headshot Dan Pawliw, GraceMed's new CEO TORONTO, June 11, 2025 (GLOBE NEWSWIRE) -- GraceMed, a leading consolidator in...
Intelligent Bio Solutions Expands U.S. Forensic Market Presence, Seeks FDA Clearance for Breakthrough Fingerprint Drug Testing
SMARTOX has deployed over 50 of INBS’ Intelligent Fingerprinting Drug Screening Readers and facilitated over 7,000 screening tests, including more...
Vivos Therapeutics Completes Acquisition of The Sleep Center of Nevada
Transaction brings OSA diagnostic revenue to Vivos, plus Vivos’ highly effective OSA treatment options to thousands of potential patients in...
OKYO Pharma to Present at the Bio International Convention
LONDON and NEW YORK, June 11, 2025 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing...
Artelo Biosciences Announces Reverse Stock Split
Shares Expected to Begin Trading on a Split-Adjusted Basis on June 13, 2025SOLANA BEACH, Calif., June 11, 2025 (GLOBE NEWSWIRE)...
IntelGenx Announces Rebranding to Nualtis, Signaling Strategic Evolution and Renewed Vision
MONTREAL, June 11, 2025 (GLOBE NEWSWIRE) -- IntelGenx, a leader in oral thin film drug delivery, today announced its official...